AWD 12187
Latest Information Update: 23 Aug 2007
At a glance
- Originator elbion
- Class
- Mechanism of Action Phosphodiesterase VII inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 08 Dec 2003 No development reported - Preclinical for Allergy in Germany (unspecified route)
- 06 Jun 2000 Preclinical development for Allergy in Germany (Unknown route)